Kimberly Chong

Array ( [id] => 5417198 [patent_doc_number] => 20090043085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA' [patent_app_type] => utility [patent_app_number] => 12/143002 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 31424 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20090043085.pdf [firstpage_image] =>[orig_patent_app_number] => 12143002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417196 [patent_doc_number] => 20090043083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA' [patent_app_type] => utility [patent_app_number] => 12/138215 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22717 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20090043083.pdf [firstpage_image] =>[orig_patent_app_number] => 12138215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6577599 [patent_doc_number] => 20100273854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING NADPH OXIDASE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/452123 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20689 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273854.pdf [firstpage_image] =>[orig_patent_app_number] => 12452123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5311040 [patent_doc_number] => 20090018321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA' [patent_app_type] => utility [patent_app_number] => 12/137914 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12994 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018321.pdf [firstpage_image] =>[orig_patent_app_number] => 12137914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039526 [patent_doc_number] => 20110092575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'SIRNA OF HUMAN OSTEOPONTIN' [patent_app_type] => utility [patent_app_number] => 12/737040 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3493 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092575.pdf [firstpage_image] =>[orig_patent_app_number] => 12737040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886945 [patent_doc_number] => 20080261277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'pRNA chimera' [patent_app_type] => utility [patent_app_number] => 12/156514 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 14481 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261277.pdf [firstpage_image] =>[orig_patent_app_number] => 12156514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5381692 [patent_doc_number] => 20090193531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Methods and compositions for RNA Interference' [patent_app_type] => utility [patent_app_number] => 12/152837 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 24711 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12152837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4552881 [patent_doc_number] => 07820635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'RNAi probes targeting cancer-related proteins' [patent_app_type] => utility [patent_app_number] => 12/116083 [patent_app_country] => US [patent_app_date] => 2008-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 32 [patent_no_of_words] => 7659 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820635.pdf [firstpage_image] =>[orig_patent_app_number] => 12116083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071350 [patent_doc_number] => 20110046201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'METHODS AND COMPOSITIONS FOR SEAMLESS CLONING OF NUCLEIC ACID MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/112803 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 39462 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046201.pdf [firstpage_image] =>[orig_patent_app_number] => 12112803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4851975 [patent_doc_number] => 20080317717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'ANTI-HEPATITIS B VIRUS RIBOZYMAL NUCLEIC ACID' [patent_app_type] => utility [patent_app_number] => 12/112590 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7449 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317717.pdf [firstpage_image] =>[orig_patent_app_number] => 12112590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538724 [patent_doc_number] => 20100204309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'OLIGONUCLEOTIDE COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/450698 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10118 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204309.pdf [firstpage_image] =>[orig_patent_app_number] => 12450698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585972 [patent_doc_number] => 20090105174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'NUCLEIC ACIDS HYBRIDIZABLE TO MICRO RNA AND PRECURSORS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/105562 [patent_app_country] => US [patent_app_date] => 2008-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25453 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105174.pdf [firstpage_image] =>[orig_patent_app_number] => 12105562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8464563 [patent_doc_number] => 20120269732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'METHODS OF CONTROLLING TUMORIGENESIS AND DIAGNOSING THE RISK THEREOF' [patent_app_type] => utility [patent_app_number] => 12/595824 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 20785 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12595824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433644 [patent_doc_number] => 20100278809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Inhibitors of MRP4 for the Treatment of Vascular Disorders' [patent_app_type] => utility [patent_app_number] => 12/595122 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16584 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278809.pdf [firstpage_image] =>[orig_patent_app_number] => 12595122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8385944 [patent_doc_number] => 08263329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer' [patent_app_type] => utility [patent_app_number] => 12/079900 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 31391 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12079900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6349533 [patent_doc_number] => 20100249052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'DSRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/593202 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22878 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249052.pdf [firstpage_image] =>[orig_patent_app_number] => 12593202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626762 [patent_doc_number] => 08796442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Combined hairpin-antisense compositions and methods for modulating expression' [patent_app_type] => utility [patent_app_number] => 12/052658 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14815 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12052658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6322968 [patent_doc_number] => 20100196886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'SCREENING, DIAGNOSING, TREATING AND PROGNOSIS OF PATHOPHYSIOLOGIC STATUS BY RNA REGULATION' [patent_app_type] => utility [patent_app_number] => 12/450124 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 36054 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196886.pdf [firstpage_image] =>[orig_patent_app_number] => 12450124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324238 [patent_doc_number] => 20090062228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'piRNA and uses related thereto' [patent_app_type] => utility [patent_app_number] => 12/075121 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 41069 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062228.pdf [firstpage_image] =>[orig_patent_app_number] => 12075121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6619108 [patent_doc_number] => 20100324115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Treatment of Squamous Cell Carcinoma with HSP27 Antisense Oligonucleotides and Radiotherapy' [patent_app_type] => utility [patent_app_number] => 12/528118 [patent_app_country] => US [patent_app_date] => 2008-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4211 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324115.pdf [firstpage_image] =>[orig_patent_app_number] => 12528118 [rel_patent_id] =>[rel_patent_doc_number] =>)